UK markets closed

Psychemedics Corporation (PMD)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.5700-0.1100 (-4.10%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
21,596
22,098
25,240
24,909
21,360
-
Cost of revenue
13,266
13,685
15,949
14,645
16,474
-
Gross profit
8,330
8,413
9,291
10,264
4,886
-
Operating expenses
Research development
1,055
1,144
1,326
1,130
1,280
-
Selling general and administrative
10,235
10,190
9,048
8,925
9,672
-
Total operating expenses
11,290
11,334
10,374
10,055
10,952
-
Operating income or loss
-2,960
-2,921
-1,083
209
-6,066
-
Total other income/expenses net
-517
-517
43
-1,030
-140
-
Income before tax
-3,477
-3,438
-1,040
-821
-6,206
-
Income tax expense
981
716
44
-156
-2,347
-
Income from continuing operations
-4,458
-4,154
-1,084
-665
-3,859
-
Net income
-4,458
-4,154
-1,084
-665
-3,859
-
Net income available to common shareholders
-4,458
-4,154
-1,084
-665
-3,859
-
Basic EPS
-0.68
-
-0.19
-0.12
-0.70
0.28
Diluted EPS
-0.68
-
-0.19
-0.12
-0.70
0.28
Basic average shares
5,705
-
5,681
5,549
5,524
5,517
Diluted average shares
5,705
-
5,705
5,549
5,524
5,517